The Antiretroviral nelfinavir mesylate, a potential therapy for systemic scleroderma
admin 25th September 2017 Uncategorised 0Arthritis & Rheumatism
More: The Antiretroviral nelfinavir mesylate, a potential therapy for systemic scleroderma
Source: MDlinx